Click to View: 1.
Click to Enlarge Slide 1. "What's New and Upcoming With Contraceptive Technologies: From Research to the Field" PRB, November 8, 2010
Click to View: 2. New Leadership
Click to Enlarge Slide 2. New Leadership
Click to View: 3. TOPICS:
Click to Enlarge Slide 3. TOPICS:
Click to View: 4. Family Planning:  Responds to a panoply of problems
Click to Enlarge Slide 4. Family Planning: Responds to a panoply of problems
Click to View: 5. Family Planning Use and Need in Africa
Click to Enlarge Slide 5. Family Planning Use and Need in Africa
Click to View: 6. Priorities in Contraceptive Technology
Click to Enlarge Slide 6. Priorities in Contraceptive Technology
Click to View: 7. Existing Contraceptive Technology
Click to Enlarge Slide 7. Existing Contraceptive Technology
Click to View: 8. Long-Acting & Permanent Methods
Click to Enlarge Slide 8. Long-Acting & Permanent Methods
Click to View: 9. Characteristics of LAPMs
Click to Enlarge Slide 9. Characteristics of LAPMs
Click to View: 10. Zarin® (Sino-implant II)
Click to Enlarge Slide 10. Zarin® (Sino-implant II)
Click to View: 11. New hormonal implants:Comparison of Sino-Implant, Jadelle, Implanon
Click to Enlarge Slide 11. New hormonal implants: Comparison of Sino-Implant, Jadelle, Implanon
Click to View: 12. NES/EE CVR
Click to Enlarge Slide 12. NES/EE CVR
Click to View: 13. NES 150µg/EE 15 µg CVR
Click to Enlarge Slide 13. NES 150µg/EE 15 µg CVR
Click to View: 14. The CVR is an effective, convenient, easily-used new contraceptive method.
Click to Enlarge Slide 14. The CVR is an effective, convenient, easily-used new contraceptive method.
Click to View: 15. The Best of Both Worlds
Click to Enlarge Slide 15. The Best of Both Worlds
Click to View: 16. The levonorgestrel intrauterine system
Click to Enlarge Slide 16. The levonorgestrel intrauterine system
Click to View: 17. Change in hemoglobin during 5 years of use
Click to Enlarge Slide 17. Change in hemoglobin during 5 years of use
Click to View: 18. New formulation of Depo-Provera: Depo-subQ Provera 104, for delivery with Uniject
Click to Enlarge Slide 18. New formulation of Depo-Provera: Depo-subQ Provera 104, for delivery with Uniject
Click to View: 19. The LD Formulation of Depo-Provera Is Efficacious at Lower Peak Concentrations
Click to Enlarge Slide 19. The LD Formulation of Depo-Provera Is Efficacious at Lower Peak Concentrations
Click to View: 20. SILCS Diaphragm: “One size fits most”
Click to Enlarge Slide 20. SILCS Diaphragm: “One size fits most”
Click to View: 21. Woman’s Condom
Click to Enlarge Slide 21. Woman’s Condom
Click to View: 22. Product Features
Click to Enlarge Slide 22. Product Features
Click to View: 23. Woman’s Condom:Performance Objectives and Plans
Click to Enlarge Slide 23. Woman’s Condom: Performance Objectives and Plans
Click to View: 24. Current Options for Men
Click to Enlarge Slide 24. Current Options for Men
Click to View: 25. Approaches to Male Contraception:Targeting the sperm
Click to Enlarge Slide 25. Approaches to Male Contraception: Targeting the sperm
Click to View: 26. Sperm suppression and contraceptive protection provided by norethisterone enantate (Net-En) combined with testosterone undecanoate (TU) in healthy men
Click to Enlarge Slide 26. Sperm suppression and contraceptive protection provided by norethisterone enantate (Net-En) combined with testosterone undecanoate (TU) in healthy men
Click to View: 27. New Contraceptive Methods Needed
Click to Enlarge Slide 27. New Contraceptive Methods Needed
Click to View: 28. Research & Development Priorities in Contraception for the Next Decade
Click to Enlarge Slide 28. Research & Development Priorities in Contraception for the Next Decade
Click to View: 29. The Population Council
Click to Enlarge Slide 29. The Population Council
Click to View: 30. 58 technologies in the contraceptive R&D pipeline
Click to Enlarge Slide 30. 58 technologies in the contraceptive R&D pipeline
Click to View: 31. New Contraceptive Rings
Click to Enlarge Slide 31. New Contraceptive Rings
Click to View: 32. Progesterone Vaginal  Ring :
Click to Enlarge Slide 32. Progesterone Vaginal Ring :
Click to View: 33. Progesterone receptor ModulatorsUlipristal Vaginal Ring
Click to Enlarge Slide 33. Progesterone receptor Modulators Ulipristal Vaginal Ring
Click to View: 34. Dual-protection Vaginal Ring
Click to Enlarge Slide 34. Dual-protection Vaginal Ring
Click to View: 35. Advantages of Vaginal Rings
Click to Enlarge Slide 35. Advantages of Vaginal Rings
Click to View: 36. TRANSDERMALS
Click to Enlarge Slide 36. TRANSDERMALS
Click to View: 37. New development concept for transdermal contraception
Click to Enlarge Slide 37. New development concept for transdermal contraception
Click to View: 38. Transdermal Contraceptives
Click to Enlarge Slide 38. Transdermal Contraceptives
Click to View: 39. Pericoital use of  LNG vaginal gel
Click to Enlarge Slide 39. Pericoital use of LNG vaginal gel
Click to View: 40. Vaginal Gels “On demand”
Click to Enlarge Slide 40. Vaginal Gels “On demand”
Click to View: 41. Percentage of Anovulation in 5-day post-LNG Gel, 0.75 mg/4 mL or LNG oral 0.75 mg x 2
Click to Enlarge Slide 41. Percentage of Anovulation in 5-day post-LNG Gel, 0.75 mg/4 mL or LNG oral 0.75 mg x 2
Click to View: 42. Is there a Future for Male Contraception ?
Click to Enlarge Slide 42. Is there a Future for Male Contraception ?
Click to View: 43. 9342 Men
Click to Enlarge Slide 43. 9342 Men
Click to View: 44. Willingness to Use New Male Method
Click to Enlarge Slide 44. Willingness to Use New Male Method
Click to View: 45. HORMONAL METHODS FOR MALE CONTRACEPTION
Click to Enlarge Slide 45. HORMONAL METHODS FOR MALE CONTRACEPTION
Click to View: 46. MENT for Male Contraception A tissue-selective androgen
Click to Enlarge Slide 46. MENT for Male Contraception A tissue-selective androgen
Click to View: 47. MENT Implant for Men
Click to Enlarge Slide 47. MENT Implant for Men
Click to View: 48. Effect of MENT AC Implants on Sperm Count
Click to Enlarge Slide 48. Effect of MENT AC Implants on Sperm Count
Click to View: 49. NON-HORMONAL METHODS FOR MALE CONTRACEPTION
Click to Enlarge Slide 49. NON-HORMONAL METHODS FOR MALE CONTRACEPTION
Click to View: 50. New targets for Contraception
Click to Enlarge Slide 50. New targets for Contraception
Click to View: 51. New Promising Targets
Click to Enlarge Slide 51. New Promising Targets
Click to View: 52. Stages of drug development : Reported averages
Click to Enlarge Slide 52. Stages of drug development : Reported averages
Click to View: 53. Typical Drug Development Attrition Rates: Included in development cost estimates
Click to Enlarge Slide 53. Typical Drug Development Attrition Rates: Included in development cost estimates
Click to View: 54. The Future:Meeting the Unmet Needs
Click to Enlarge Slide 54. The Future: Meeting the Unmet Needs
Click to View: 55. Acknowledgements
Click to Enlarge Slide 55. Acknowledgements
Click to View: 56. Contraceptive Introduction:Where the rubber meets the road
Click to Enlarge Slide 56. Contraceptive Introduction: Where the rubber meets the road
Click to View: 57. Overview
Click to Enlarge Slide 57. Overview
Click to View: 58. A job well done: FP “revolution”
Click to Enlarge Slide 58. A job well done: FP “revolution”
Click to View: 59. But more work needed
Click to Enlarge Slide 59. But more work needed
Click to View: 60. Systems framework forcontraceptive introduction
Click to Enlarge Slide 60. Systems framework for contraceptive introduction
Click to View: 61. Time: not always on our side
Click to Enlarge Slide 61. Time: not always on our side
Click to View: 62. Currently married women, urban residence, Uttar Pradesh, India
Click to Enlarge Slide 62. Currently married women, urban residence, Uttar Pradesh, India
Click to View: 63. Lessons learned from Norplant
Click to Enlarge Slide 63. Lessons learned from Norplant
Click to View: 64. Introduction variants
Click to Enlarge Slide 64. Introduction variants
Click to View: 65. Variant 1: Sino-implant (II)
Click to Enlarge Slide 65. Variant 1: Sino-implant (II)
Click to View: 66. Shanghai Dahua Pharmaceutical Co., Ltd.,Shanghai, China
Click to Enlarge Slide 66. Shanghai Dahua Pharmaceutical Co., Ltd., Shanghai, China
Click to View: 67. Sino-implant (II) Registration StatusOct 2010
Click to Enlarge Slide 67. Sino-implant (II) Registration Status Oct 2010
Click to View: 68. Steps and sequencing for new product introduction: Sino-implant (II)
Click to Enlarge Slide 68. Steps and sequencing for new product introduction: Sino-implant (II)
Click to View: 69. Variant 2: CBD of injectables – Strengthening the service delivery system
Click to Enlarge Slide 69. Variant 2: CBD of injectables – Strengthening the service delivery system
Click to View: 70. CBD – DMPA Technical Consultation, June 2009
Click to Enlarge Slide 70. CBD – DMPA Technical Consultation, June 2009
Click to View: 71. Opportunities for paramedical professional provision of injectables – 2004
Click to Enlarge Slide 71. Opportunities for paramedical professional provision of injectables – 2004
Click to View: 72. Current status of paraprofessional provision of injectable contraception - 2010
Click to Enlarge Slide 72. Current status of paraprofessional provision of injectable contraception - 2010
Click to View: 73. Attributes of introduction success
Click to Enlarge Slide 73. Attributes of introduction success
Click to View: 74. Conclusions
Click to Enlarge Slide 74. Conclusions